The World Health Organisation (WHO) said on Friday (December 30) that it is in touch with Uzbekistan's authorities after the government and multiple media reports said that 18 children in the country died after consuming Dok-1 Max,&nbsp;a cold and flu syrup manufactured by Indian-based pharmaceutical Marion Biotech.

"We are in touch with the Uzbek authorities and are still in the process of gathering information and validating these reports," the WHO told news agency ANI.&nbsp;

Earlier, Uzbekistan's health ministry had said that the Dok-1 Max syrup contained ethylene glycol,&nbsp;a toxic substance. The ministry said the syrup was administered in doses that were higher than the standard for children, either by their parents who mistook it for an anti-cold remedy or on pharmacists' advice. The victims, most of them between five months and four years old, died of acute renal failure, news agency AFP reported on Thursday.&nbsp;

ALSO READ | <a href="https://www.wionews.com/india-news/doc-1-max-india-made-cough-syrup-blamed-for-childrens-deaths-in-uzbekistan-probe-begins-547776">India-made cough syrup blamed for kids' deaths in Uzbekistan, production halted at unit</a>

Sales of all medicines by Marion Biotech have been temporarily suspended in Uzbekistan.&nbsp;

Currently, Marion Biotech has halted production of all medicines at its unit in Noida, Uttar Pradesh. Taking to Twitter, India's health minister Mansukh Mandaviya said on Friday, "All manufacturing activities of Marion Biotech at Noida unit have been stopped yesterday night, while further investigation is ongoing."

WION Dispatch | Uzbekistan: 18 children dead due to cough syrup made by Indian firm

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false">
<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/wion-dispatch-uzbekistan-18-children-dead-due-to-cough-syrup-made-by-indian-firm-547780/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>
</div>
<a class="close-mark close-div" href="#" id="jqclosemark">×</a></div>

&nbsp;

Additionally, India's chemicals and fertilisers ministry issued an order on Thursday where it laid out specifications to regulate the sale of ethylene glycol from the end of March.&nbsp;

The deaths of 18 children in Uzbekistan come months after at least 70 children in Gambia died from acute kidney injury (AKI) linked to the consumption of cough and cold syrups manufactured by Maiden Pharmaceuticals, another Indian firm.&nbsp;

(With inputs from agencies)&nbsp; 
&nbsp;

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1  width=&quot;100%&quot;"></iframe>

You can now write for wionews.com and be a part of the community. Share your stories and opinions with us <a href="https://www.wionews.com/content-contribution-registration-form">here</a>.

The World Health Organisation (WHO) said on Friday (December 30) that it is in touch with Uzbekistan's authorities after the government and multiple media reports said that 18 children in the country died after consuming Dok-1 Max, a cold and flu syrup manufactured by Indian-based pharmaceutical Marion Biotech.

The World Health Organisation (WHO) said on Friday (December 30) that it is in touch with Uzbekistan's authorities after the government and multiple media reports said that 18 children in the country died after consuming Dok-1 Max, a cold and flu syrup manufactured by Indian-based pharmaceutical Marion Biotech. "We are in touch with the Uzbek authorities and are still in the process of gathering information and validating these reports," the WHO told news agency ANI. Earlier, Uzbekistan's health ministry had said that the Dok-1 Max syrup contained ethylene glycol, a toxic substance. The ministry said the syrup was administered in doses that were higher than the standard for children, either by their parents who mistook it for an anti-cold remedy or on pharmacists' advice. The victims, most of them between five months and four years old, died of acute renal failure, news agency AFP reported on Thursday. ALSO READ | India-made cough syrup blamed for kids' deaths in Uzbekistan, production halted at unit Sales of all medicines by Marion Biotech have been temporarily suspended in Uzbekistan. Currently, Marion Biotech has halted production of all medicines at its unit in Noida, Uttar Pradesh. Taking to Twitter, India's health minister Mansukh Mandaviya said on Friday, "All manufacturing activities of Marion Biotech at Noida unit have been stopped yesterday night, while further investigation is ongoing." WION Dispatch | Uzbekistan: 18 children dead due to cough syrup made by Indian firm × Additionally, India's chemicals and fertilisers ministry issued an order on Thursday where it laid out specifications to regulate the sale of ethylene glycol from the end of March. The deaths of 18 children in Uzbekistan come months after at least 70 children in Gambia died from acute kidney injury (AKI) linked to the consumption of cough and cold syrups manufactured by Maiden Pharmaceuticals, another Indian firm. (With inputs from agencies) WATCH WION LIVE HERE You can now write for wionews.com and be a part of the community. Share your stories and opinions with us here.

Uzbekistan cough syrup deaths: WHO says it's in touch with Uzbek authorities

Uzbekistan has alleged that at least 18 children in the country have died after consuming an India-manufactured cough syrup. The Drugs Controller General of India has sought more information regarding the incident from the Uzbek regulator.

WION Dispatch | Uzbekistan: 18 children dead due to cough syrup made by Indian firm

Uzbekistan's government has announced a probe into the deaths of 18 children who consumed Dok-1 Max- a cold and flu syrup manufactured by Indian-based pharmaceutical Marion Biotech. A report by AKI press on Wednesday said that a criminal probe has been launched against officials of the company importer Quramax Medical and the State Centre&nbsp;for Standardisation of Medicines for the production, and acquisition of medicines of poor quality leading to loss of lives.&nbsp;

The report said that several people were detained in connection with the deaths of these 18 children, and the suspects would face 10-15 years in prison.&nbsp;

The State Centre&nbsp;for Expertise and Standardisation of Medicines, Medical Devices and Medical Equipment of the Pharmaceutical Network Development Agency concluded that Dok-1 Max did not meet the requirements of normative documents, the report added.&nbsp;

It also said that previously, Uzbekistan's health ministry had said that ethylene glycol was found in cold and flu syrup.&nbsp;

ALSO READ|&nbsp;<a href="https://www.wionews.com/world/indias-maiden-pharmaceuticals-culpable-for-cough-syrup-deaths-gambia-panel-545215">India's Maiden Pharmaceuticals culpable for cough syrup deaths: Gambia panel</a>

Marion Biotech has not responded to the above accusations 
Based in Noida, Uttar Pradesh, the pharmaceutical makes medicines for anti-cold, pain and fever, food supplements and many other medicinal products.&nbsp;

According to Marion Biotech's website, the Dok 1 Max syrup is a combination of three medical ingredients that reduce "symptoms associated with cold, flu, cough, fever and other infectious upper respiratory tract diseases which are accompanied by chill, cough and fever."

The pharmaceutical says that the ingredients of Dok-1 Max are usually well tolerated at the recommended doses. "Occasionally you may experience a skin rash, abdominal pain, increased blood pressure, dizziness and other allergic reactions," the website reads.&nbsp;

Furthermore, reports claim, that children&nbsp;had taken the medicine for two&nbsp;to seven&nbsp;days with doses up to 5 ml, at least three to four times a day, which exceeds the standard dose for children. Meanwhile, the&nbsp;World Health Organization, told the Indian Express, "WHO is in contact with health authorities in Uzbekistan and is ready to assist in further investigations."&nbsp;

This development in Uzbekistan comes months after at least 70 children in Gambia died from acute kidney injury (AKI) linked to the consumption of cough and cold syrups manufactured by Maiden Pharmaceuticals, another company from India. Last week, a parliamentary panel in Gambia said that the government should pursue legal action against Maiden Pharmaceuticals for exporting contaminated drugs. The panel also demanded that the company should be blacklisted and its products be banned in markets in the country.&nbsp;

&nbsp;

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1  width=&quot;100%&quot;"></iframe>

You can now write for wionews.com and be a part of the community. Share your stories and opinions with us <a href="https://www.wionews.com/content-contribution-registration-form">here</a>.

Uzbekistan's government has announced a probe into the deaths of 18 children who consumed Dok-1 Max- a cold and flu syrup manufactured by Indian-based pharmaceutical Marion Biotech.

Uzbekistan's government has announced a probe into the deaths of 18 children who consumed Dok-1 Max- a cold and flu syrup manufactured by Indian-based pharmaceutical Marion Biotech. A report by AKI press on Wednesday said that a criminal probe has been launched against officials of the company importer Quramax Medical and the State Centre for Standardisation of Medicines for the production, and acquisition of medicines of poor quality leading to loss of lives. The report said that several people were detained in connection with the deaths of these 18 children, and the suspects would face 10-15 years in prison. The State Centre for Expertise and Standardisation of Medicines, Medical Devices and Medical Equipment of the Pharmaceutical Network Development Agency concluded that Dok-1 Max did not meet the requirements of normative documents, the report added. It also said that previously, Uzbekistan's health ministry had said that ethylene glycol was found in cold and flu syrup. ALSO READ| India's Maiden Pharmaceuticals culpable for cough syrup deaths: Gambia panel Marion Biotech has not responded to the above accusations Based in Noida, Uttar Pradesh, the pharmaceutical makes medicines for anti-cold, pain and fever, food supplements and many other medicinal products. According to Marion Biotech's website, the Dok 1 Max syrup is a combination of three medical ingredients that reduce "symptoms associated with cold, flu, cough, fever and other infectious upper respiratory tract diseases which are accompanied by chill, cough and fever." The pharmaceutical says that the ingredients of Dok-1 Max are usually well tolerated at the recommended doses. "Occasionally you may experience a skin rash, abdominal pain, increased blood pressure, dizziness and other allergic reactions," the website reads. Furthermore, reports claim, that children had taken the medicine for two to seven days with doses up to 5 ml, at least three to four times a day, which exceeds the standard dose for children. Meanwhile, the World Health Organization, told the Indian Express, "WHO is in contact with health authorities in Uzbekistan and is ready to assist in further investigations." This development in Uzbekistan comes months after at least 70 children in Gambia died from acute kidney injury (AKI) linked to the consumption of cough and cold syrups manufactured by Maiden Pharmaceuticals, another company from India. Last week, a parliamentary panel in Gambia said that the government should pursue legal action against Maiden Pharmaceuticals for exporting contaminated drugs. The panel also demanded that the company should be blacklisted and its products be banned in markets in the country. WATCH WION LIVE HERE You can now write for wionews.com and be a part of the community. Share your stories and opinions with us here.

Uzbekistan says 18 children dead after consuming Indian pharma's syrup; probe launched: Report

Indian Prime Minister Narendra Modi held talks with Russian President Vladimir Putin on the sidelines of 22nd SCO summit in Samarkand, Uzbekistan. During this, PM Modi told Putin that this wasn’t the era of war, while also underlining the significance of democracy, dialogue and diplomacy.

'This is not as era of war': Indian PM Modi tells Russian President Putin on sidelines of SCO summit

The SCO held its first in-person summit in Samarkand after two years of disruption caused by the COVID-19 pandemic. The summit had the participation of several world leaders such as Chinese President Xi Jinping, Putin, Raisi, and Shehbaz Sharif among others from the Central Asian countries. Watch in the key takeaways from the summit.

22nd SCO Summit key takeaways: Indian PM Modi urges Russian President Putin to end Ukraine war

It is day 2 of the SCO Summit and the world leaders have arrived at Samarkand, Uzbekistan. The leaders of Russia, China, India, Pakistan and four central Asian nations will be under one roof.

22nd SCO Summit: Indian PM Modi is all set to meet Russian President Vladimir Putin today

It is day 2 of the SCO Summit and the world leaders have arrived at Samarkand, Uzbekistan for the meet. The leaders of the organisation are all set to discuss regional security challenges and energy supplies.

22nd SCO Summit: Xi, Putin, Modi to meet under one roof

Indian Prime minister Narendra Modi has arrived in the city of Samarkand on Thursday to attend the Shanghai Cooperation Summit (SCO). PM Modi is scheduled to meet Russian President Vladimir Putin on the second day of the summit.

SCO Summit: Indian PM Modi to hold crucial bilateral with Russian President Putin

Indian Prime Minister Narendra Modi has no plans to meet his Pakistani counterpart Shehbaz Sharif on the sidelines of the Shanghai Cooperation Organisation (SCO) being held in Samarkand, Uzbekistan on September 15 and 16.

Reports: No plans for Modi-Shehbaz meeting on sidelines of SCO summit

The 22nd Summit of the Council of Heads of the Shanghai Cooperation Organization Member States is set to begin in the historical city of Samarkand in Uzbekistan. Indian Prime Minister Narendra Modi and Chinese President Xi Jinping will come face-to-face on Friday for the first time since deadly border clashes in 2020.

22nd SCO Summit: Modi, Xi to come face-to-face for first time since border clashes

Indian Prime Minister Narendra Modi who is in Samarkand, addressed the SCO leaders on day two of the summit. Now during his speech, the Indian Prime Minister emphasized on how the country supports mutual trust among SCO leaders.

WION Dispatch: SCO Summit 2022: 'We are supporting innovation in every sector'

Iran is set to become a permanent member of the eight-member regional body. Tehran signed a memorandum of obligations which brings it one step closer to becoming a permanent member of the Shanghai Corporation Organization.

WION Dispatch: Iran signs memorandum of obligation, gain full SCO membership after 15 years

Heads of 11 member states attended day one of the SCO Summit in Samarkand and at dinner on Thursday, Chinese President Xi Jinping was missing from those pictures.

SCO Summit 2022: China's Xi skips dinner with Putin, allies as Covid precaution

Indian Prime Minister Narendra Modi is expected to have key bilateral meet with Russia's President Vladimir Putin, Iranian and Uzbek leaders. He will be exchanging his views on regional and international issues during his meet with the Russian President. PM Modi will also be discussing issues of strategic ability, situation in the Asia Pacific and bilateral cooperation within the United Nations and G20.

SCO summit day 2 : India's PM Modi to hold bilateral meet with Iranian, Uzbek and Russian leaders

It is day 2 of the SCO Summit and the world leaders have arrived at Samarkand, Uzbekistan for the meet. Indian Prime Minister Narendra Modi has met Turkish President Recep Tayyip Erdogan just a few moments ago. This is their meeting on the sidelines of the SCO Summit.

SCO Summit 2022: Modi Putin to talk on strategic ability

SCO Summit 2022 | Xi: Will support India for Presidency next year

Indian Prime minister Narendra Modi meets world leaders at SCO summit, Uzbekistan. During his address PM Modi said that, "We are focussing on people-centric development model. We are supporting innovation in every sector."

22nd SCO Summit: PM Modi addresses SCO leaders, promotes India's innovation

SCO leaders gather for the main meet in Samarkand, key Modi-Putin meeting today

Day 2 of SCO Summit: First in-person meet since the pandemic, talks between leaders underway

Indian foreign ministry held media briefing ahead of Prime Minister Narendra Modi's Uzbekistan visit. During this, Foreign Secretary Vinay Kwatra said that PM Modi will reach Samarkand on Thursday evening for the SCO summit and is likely to meet Russian President Vladimir Putin and some other leaders on the sidelines of the summit.

Indian foreign ministry briefing on SCO summit: PM Modi to travel to Uzbekistan today

The leaders of China and Russia- Xi Jinping and Vladimir Putin, are making rare trips to Uzbekistan for SCO Summit amidst the ongoing war in Ukraine. Both China and Russia have long sought to position the SCO as an alternative to the western multilateral groups, they could possibly be closer to this aim now than ever before.

Putin, Xi make rare trip abroad for SCO Summit in Uzbekistan

The SCO Summit is all set to take place in Samarkand, an Uzbek city that is rich in history and culture. WION's Siddhant Sibbal tells you more about the city that is set to host this mega summit.

WION Ground Report: A glimpse of Uzbekistan's cultural capital Samarkand

WION's Siddhant Sibbal speaks to Rakhmatulla I Nurimbetov, National Coordinator for Uzbekistan for SCO. Talking about the expansion, Nurimbetov said "will sign MoU with Iran this time and next time, during Indian summit of SCO, Iran will become a full member of the group".

''Iran to be permanent SCO member from next year', says Uzbek SCO coordinator Nurimbetov

In Uzbekistan bullet train started functioning a few years ago and now it has become a cheap and fast mode of transport. High-speed rail links the past with the future. WION's Siddhant Sibbal gets you the ground report.

WION Ground Report: The Tashkent-Samarkand high-speed rail

China’s President Xi Jinping and Russian President Vladimir Putin will hold talks on the sidelines of the Shanghai Cooperation Organisation (SCO) summit in Uzbekistan, which Indian Prime Minister Narendra Modi will also attend.

SCO Summit 2022: Chinese President Xi Jinping to hold talks with Russia's Putin at Uzbekistan summit

The 22nd summit of the council of heads of the Shanghai Cooperation Organization (SCO) member states is set to take place in the historical city of Samarkand in Uzbekistan from September 15 to 16.

22nd summit of council of the heads of SCO member states to begin in Uzbekistan today

As Samarkand hosts the SCO or Shanghai cooperation organization summit, we bring you sights of this fabled city of Uzbekistan. Our correspondent Sidhant Sibal travels to Gur e Amir, the tomb of Timur and explains its significance.

Uzbekistan: Tomb of Timur and its connect with India

The leaders of the West will have their eyes on the Central Asian nation of Uzbekistan. The country is hosting the Shanghai cooperation organization Summit this year where the grouping is said to expand further.

Kremlin: SCO summit will showcase an alternative to west, Putin looks to form anti-west bloc

The Shanghai Cooperation Organization was formed in 2001 after the collapse of the Soviet Union in 1991.The grouping includes Russia, China, India, Pakistan, Uzbekistan, Tajikistan, Kyrgyzstan and Kazakhstan. The SCO has focused on regional security and counter-terrorism among other key focus areas.

What made India join the SCO?

Chinese President Xi Jinping will visit Central Asia this week on his first trip out of the country since the COVID-19 pandemic, attending the regional Shanghai Cooperation Organization (SCO) Summit in Uzbekistan.

Chinese President Xi Jinping to visit Central Asia on first post-pandemic foreign trip

The bullet train is something that has been much talked about in India, it is being built with Japanese support and plans to connect Mumbai and Ahmedabad. In Uzbekistan bullet train started functioning a few years ago and now it has become a cheap and fast mode of transport, our correspondent Siddhant Sibbal brings in more.

WION Dispatch | The Tashkent-Samarkand high-speed rail | WION ground report from Uzbekistan

uzbekistan

Uzbekistan, News on Uzbekistan, stories on Uzbekistan, articles on Uzbekistan, Uzbekistan stories at Wion, Uzbekistan news, Uzbekistan latest news